Stay updated on IGN002 Clinical Trial in Refractory NHL
Sign up to get notified when there's something new on the IGN002 Clinical Trial in Refractory NHL page.

Latest updates to the IGN002 Clinical Trial in Refractory NHL page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedThe study page now displays a 403 Forbidden message with a Home link instead of the prior mostly empty content area.SummaryDifference0.6%

- Check17 days agoChange DetectedThe page no longer displays the 403 Forbidden message or its Home link; no study-specific details are visible in their place.SummaryDifference0.5%

- Check31 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record content, replacing it with an access-restricted message. This blocks viewing the trial details and related information on that record.SummaryDifference15%

- Check52 days agoChange DetectedRevision: v3.6.6 is now in place, replacing v3.6.5 for the page. This update reflects a backend platform/template revision and does not change the study data presented on the page.SummaryDifference0.1%

- Check73 days agoChange DetectedThe page now shows revision v3.6.5 instead of v3.6.4, signaling a minor update to the ClinicalTrials.gov entry.SummaryDifference0.1%

Stay in the know with updates to IGN002 Clinical Trial in Refractory NHL
Enter your email address, and we'll notify you when there's something new on the IGN002 Clinical Trial in Refractory NHL page.